Table 1 Comparison of histological and clinical findings between different groups
Characteristics | Primary intestinal T-cell and NK-cell lymphoma | Primary intestinal T-cell lymphomaa | ||||
|---|---|---|---|---|---|---|
| Â | NK-cell group (n=6) | T-cell group (n=32) | P-valueb | Type II EATL (n=7) | PTCL NOS (n=24) | P-valueb |
Gender (male/female) | 5/1 | 19/13 | 0.383 | 4/3 | 15/9 | 1.000 |
Age >60 years | 0 (0) | 7 (22) | 0.569 | 2 (29) | 5 (21) | 0.642 |
Abdominal pain | 3 (50) | 4 (13) | 0.063 | 0 (0) | 4 (17) | 0.550 |
Fever | 5 (83) | 12 (38) | 0.071 | 3 (43) | 9 (38) | 1.000 |
Bloody stool | 4 (67) | 17 (53) | 0.672 | 6 (86) | 10 (42) | 0.083 |
Chronic diarrhea | 1 (17) | 13 (41) | 0.383 | 4 (57) | 8 (33) | 0.384 |
Multicentric | 3 (50) | 16 (50) | 1.000 | 6 (86) | 9 (38) | 0.037c |
Perforation | 5 (83) | 11 (34) | 0.065 | 5 (71) | 6 (25) | 0.067 |
Stage (I–II/III–IV) | 5/1 | 20/12 | 0.643 | 7/0 | 12/12 | 0.026c |
Resection only | 3 (50) | 9 (28) | 0.357 | 4 (57) | 5 (21) | 0.150 |
Non-resection | 0 (0) | 12 (38) | 0.149 | 1 (14) | 10 (42) | 0.372 |
Macroscopic type (ulceration/protruding mass) | 4/2 | 24/8 | 0.644 | 5/2 | 18/6 | 1.000 |
Tumor cell size (medium/medium to large) | 3/3 | 10/22 | 0.392 | 7/0 | 14/10 | 0.066 |
CD4+ | 0 (0) | 5 (16) | 0.570 | 0 (0) | 5 (21) | 0.562 |
CD8+ | 0 (0) | 7 (22) | 0.569 | 5 (71) | 2 (8) | 0.002c |
CD56+ | 5 (83) | 12 (38) | 0.071 | 7 (100) | 5 (21) | <0.001c |
βF-1+ | 0 (0) | 15 (47) | 0.063 | 4 (57) | 11 (46) | 0.685 |
CD5+ | 0 (0) | 3 (9) | 1.000 | 3 (43) | 13 (54) | 1.000 |
CD30+ | 1 (17) | 9 (28) | 1.000 | 2 (29) | 7 (29) | 1.000 |
Granzyme B+ | 4 (67) | 13 (41) | 0.378 | 3 (43) | 10 (42) | 1.000 |
TIA-1+ | 6 (100) | 30 (94) | 1.000 | 7 (100) | 22 (92) | 1.000 |
EBER32+ | 6 (100) | 2 (6) | <0.001c | 0 (0) | 2 (8) | 1.000 |
